Gel4Med
PrivateLast Round
Grant
Jul 14, 2025
Total Funding Raised
$2.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gel4Med operates in Healthcare & Life Sciences and is based in Massachusetts. Its latest recorded funding round was a Grant round in July 2025.
Gel4Med is a biotechnology company that develops bio-inspired medical solutions for wound care and surgical reconstruction.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gel4Med Comparables
Compare Gel4Med with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imbed Biosciences | 89% | |
| GelSana Therapeutics | 86% | |
| SweetBio | 84% |
For institutional investors. Book with your work email.
Gel4Med Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 14, 2025 | ||||
| Grant | May 16, 2025 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Oct 5, 2023 | ||||
| Grant | Sep 3, 2019 | ||||
Seed | Apr 13, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gel4Med Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| MassVentures | Grant |
| Massachusetts Life Sciences Center | Grant |
| Breakout Ventures | Seed |
| U.S. Department of War | Grant |
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 117% MoM.
- Jan 20, 2026
Monthly visitors grew 526% MoM.
For institutional investors. Book with your work email.
Gel4Med Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gel4Med's valuation, stock price, and market status.
Is Gel4Med a public or private company?
Gel4Med is a private company.
What is the current stock price of Gel4Med?
Gel4Med is a private company, so its shares have no public market price. Caplight tracks Gel4Med's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gel4Med worth (valuation)?
Valuation information for Gel4Med is not publicly available.
Can I buy Gel4Med stock?
Gel4Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gel4Med's last funding round?
Gel4Med's most recent funding round was Grant on July 14, 2025.
Who are the main investors in Gel4Med?
Key investors in Gel4Med include NIH RADx, MassVentures, Massachusetts Life Sciences Center, Breakout Ventures, U.S. Department of War.
Will Gel4Med IPO soon?
No public IPO plans have been announced for Gel4Med.
How can I track Gel4Med secondary market activity?
Caplight tracks bids, offers, and trades in Gel4Med's shares on secondary markets.